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Abstract The majority of patients with DiGeorge syn- 
drome (DGS) and velo-cardio-facial syndrome (VCFS) 
and a minority of patients with non-syndromic conotrun- 
cal heart defects are hemizygous for a region of chromo- 
some 22ql 1. The chromosomal region that is commonly 
deleted is larger than 2 Mb. It has not been possible to nar- 
row the smallest region of overlap (SRO) of the deletions 
to less than ca 500 kb, which suggests that DGS/VCFS 
might be a contiguous gene syndrome. The saturation 
cloning of the SRO is being carried out, and one gene 
(TUPLE1) has been identified. By using a cosmid probe 
(M51) and fluorescence in situ hybridization, we show 
here that the anonymous DNA marker locus D22S183 is 
within the SRO, between TUPLE1 and D22S75 (probe 
N25). A second locus with weak homology to D22S183, 
recognized by cosmid M56, lies immediately outside the 
common SRO of the DGS and VCFS deletions, but inside 
the SRO of the DGS deletions. D22S183 sequences are 
strongly conserved in primates and weaker hybridizing 
signals are found in DNA of other mammalian species; no 
transcripts are however detected in polyA + RNA from 
various adult human organs. Probe M51 allows fast reli- 
able screening for 22qll  deletions using fluorescence in 
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situ hybridization. A deletion was found in 11 out of 12 
DGS patients and in 3 out of 7 VCFS patients. Two pa- 
tients inherited the deletion from a parent with mild (atyp- 
ical) symptoms. 
Introduction 
Hemizygosity for a region of chromosome 22ql l  has 
been associated with a range of congenital defects that 
have recently been brought together under the acronym 
CATCH22, denoting cardiac defects, abnormal facies, thy- 
mic hypoplasia, cleft palate, hypocalcaemia, chromosome 
22 (Wilson et al. 1993). The congenital defects include 
DiGeorge syndrome (DGS), velo-cardio-facial syndrome 
(VCFS), conotruncal anomaly face (CTAF) syndrome and 
non-syndromic conotruncal cardiac defects. The common 
embryonic origin for all these malformations could be a dis- 
turbance in the development of mesenchymal derivatives 
of the hindbrain neural crest (Bockman and Kirby 1984). 
DGS, which may be considered to lie at the severe end 
of the clinical spectrum of CATCH22, is characterized by 
hypoplasia/aplasia of the thymus and parathyroid glands, 
conotruncal heart defect and varying craniofacial dysmor- 
phologies (Conley et al. 1979). Characteristic features of 
VCFS include cleft palate, typical facies, cardiac defects 
and learning disabilities (Shprintzen et al. 1978; Goldberg 
et al. 1993). There is a considerable phenotypic overlap 
between DGS and VCFS (Goldberg et al. 1985; Stevens et 
al. 1990). The CTAF syndrome may be identical to VCFS. 
Most DGS cases appear to be sporadic, but some familial 
cases have been reported. An autosomal dominant mode 
of inheritance has been demonstrated for VCFS (Shprint- 
zen et al. 1981; Williams et al. 1985). Although the aeti- 
ology of DGS is presumed to be heterogeneous (Lammer 
and Opitz 1986), recent evidence indicates that chromo- 
some abnormalities involving a region in 22ql 1 are a fre- 
quent cause of both DGS and VCFS. Cytogenetic abnor- 
malities have been observed in 15-25% of reported DGS 
cases, and most of these are either unbalanced transloca- 
tions resulting in monosomy for the region 22q 11-pter or 
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interstitial deletions within 22ql 1 (Greenberg et al. 1988; 
Wilson et al. 1992a). Molecular studies using probes for 
various loci in the 22q 11 region have detected submicro- 
scopic deletions in more than 95% of DGS cases without 
cytogenetic abnormalit ies (Scambler et al. 1991; Driscroll 
et al. 1992a; Carey et al. 1992). Simi lar deletions have 
also been demonstrated for a high percentage of  VCFS 
(Scambler et al. 1992; Driscroll  et al. 1992b; Kel ly et al. 
1993) and CTAF cases (Burn et al. 1993). The frequency 
of  deletions is lower if patients referred from a large num- 
ber of  practising clinicians are examined and conse- 
quently the diagnostic riteria are less strict (Driscroll et 
al. 1993). Finally, 22q t 1 deletions have been detected in a 
minority of  non-syndromic patients with congenital 
conotruncal cardiac defects (Wilson et al. 1992b; Gold- 
muntz et al. 1993). 
Although the interstitial deletions in most patients ap- 
pear to be large at the DNA level (> 2 Mb), molecular 
studies have begun to narrow down the smallest region of 
overlap (SRO) of deletions (Scambler et al. t991; 
Driscroll  et al. 1992a; Desmaze et al. 1993a; L indsay et 
al. 1993; Halford et al. 1993c). At present, it is not known 
whether DGS/VCFS is caused by deletion of  a single gene 
or whether it is a so-cal led contiguous gene syndrome, 
with different extents of the deletions accounting for phe- 
notypic variability. Although the saturation cloning of the 
SRO is progressing and one candidate gene, TUPLE1,  for 
CATCH22 has recently been identified (Halford et al. 
1993c), additional genes will have to be cloned in order to 
elucidate this issue. However, one DGS case has been re- 
ported with an apparently balanced translocation t(2;22) 
(Augusseau et al. 1986). The breakpoint at 22q l l  in this 
case maps within the SRO (Lindsay et al. 1993) but does 
not disrupt TUPLE1.  Together, these data suggest that 
haplo- insuff ic iency for a locus or loci in a DiGeorge crit- 
ical region at 22ql 1 can cause multiple congenital malfor- 
mations. The critical region should tie within the SRO 
that has been narrowed to an interval of around 500 kb. In 
most CATCH22 patients, however, particularly in DiGe- 
orge patients, the deletion is larger than 2 Mb (Halford et 
al. 1993c). Therefore, the chromosomal regions adjacent 
to the SRO may harbour genes that contribute to the clin- 
ical phenotype. 
Here, we report the regional ocalization of  the anony- 
mous single-copy polymorphic marker D22S 183. By us- 
ing a cosmid probe and fluorescence in situ hybridization 
(FISH), we show that this locus maps within the most re- 
cently described SRO of the CATCH22 deletions, viz. be- 
tween TUPLE1 and the locus D22S75. 
Materials and methods 
Probes and genornic library screening 
NB84 is a 1.0-kb plasmid probe for locus D22S183, which has 
been assigned to the region 22pter-ql 1(Van Biezen et al. 1993). It 
recognizes a Pstl polymorphism (Lekanne Deprez et al. 1991). 
Plasmid HP500 (Carey et al. t992) and cosmids c4.1 (Carey et al. 
1992) and scl 1.1 (Halford et al. 1993a) were kindly provided by 
Dr. P.J. Scambler, and cos39 (Aubry et al. 1993) by Dr. M. Aubry. 
A cosmid for the locus D22S75 (N25) (Driscroll et al. 1993) was 
purchased from Oncor (Gaithersburg, Md.). This probe is supplied 
as digoxigenin-labelled DNA by the manufacturer and is pre- 
mixed with a digoxigenin-labelled control cosmid (pill7) for the 
locus D22S39 in 22q13.3. Probes for the human [3-globin gene and 
the immunoglobulin )v light chain complex were used as controls 
in Southern hybridizations. 
The chromosome-22-specific cosmid library L22NCO31"N" 
used in this work was constructed atthe Biomedical Sciences Di- 
vision, Lawrence Livermore National Laboratory, Livermore, CA 
94550, USA, under the auspices of the National Laboratory Gene 
Library Project sponsored by the US Department of Energy 
(kindly provided by Dr. P. de Jong). Cosmids M51 (33D9) and 
M56 (38A6) were isolated from this library using NB84 as the 
probe. Cosmids M69 (87D4) and M78 (114B1) were isolated us- 
ing a plasmid containing a fragment of the PDGFB gene. These 
were used as chromosome-22-specific ontrol cosmid probes. Cos- 
mid cH748 (48H7) was used as a TUPLEl-specific probe (Halford 
et al. 1993c), 
Patients and cell lines 
Patients were ascertained through clinical geneticists. Blood sam- 
pies or skin biopsies for the establishment of fibroblast cultures 
were obtained from propositi and, in some cases, their parents. 
Cell lines GM03479, GM05878 and GM00980 were obtained 
from the NIGMS Human Genetic Mutant Cell Repository (Cam- 
den, N.J,). GM03479 is from a DGS patient and has no detectable 
cytogenetic abnormality (Scambler et al. 1991). GM05878 is from 
the unaffected father of a DGS child and has a balanced transloca- 
tion t(10;22)(q26.3;qll.2) (Cannizzaro and Emanuel 1985). 
GM00980 is from a VCFS patient with a translocation t(l 1;22) 
(q25;ql t) and monosomy 22pter~tll (Fu et al. 1976). ADU is 
fi'om a DGS patient with an apparently balanced translocation 
t(2;22)(q 14.1 ;q 11.1 ) (Augusseau et al, 1986) and was kindly pro- 
vided by Dr. F. Amblard. Hybrid cell lines were established by fu- 
sion of fibroblasts from DGS patients with thymidine-kinase-defi- 
cient Chinese hamster cells (A3) followed by selection of colonies 
in HAT culture medium according to standard procedures. 
Karyotyping and FISH 
Cells were harvested from cultures of phytohaemagglutinin-stimu- 
lated lymphocytes, kin fibroblasts or established cell lines and 
spread onto slides for the production of G-banded or R-banded 
chromosome preparations and FISH. In some experiments, conflu- 
ent fibroblast cultures were enriched for Gi interphase cells by 
growth in medium with 2% fetal calf serum for 4 days. 
FISH was carried out as described by Arnoldus et al. (1990) 
with minor modifications. Cosmid probes were labelled by nick 
translation with either biotin-16-dUTP or digoxigenin-I 1-dUTP. 
The hybridization mixture contained 50 ng of each labelled cosmid 
plus 1 lag human genomic DNA as a competitor in 10 gl 70% for- 
mamide, 2xSSC (1 xSSC = 150 mM NaCl/15 mM sodium citrate, 
pH 7.0). After hybridization and washes, the slides were stained 
in three consecutive steps: (1) avidin-D-fluorescein, (2) biotinyl- 
ated goat anti-avidin plus sheep anti-digoxigenin-rhodamine, 
(3) avidin-D-fluorescein plus donkey anti-sheep-Texas Red. The 
slides were finally embedded in a glycerot mixture containing an 
antifade reagent and 4,6-diamino-2-phenyl-indole (DAPI) for 
counterstaining. In case of single-colour labelling (fluorescein), 
propidium iodide was used as the counterstain. The slides were 
analysed with a Zeiss Axioskop epifluorescence microscope, using 
various filter combinations ( ingle, double and triple band). 
For 22qll deletion analysis, metaphase spreads or G~ inte> 
phase cells were hybridized simultaneously with the test probe 
(M51) and a chromosome-22-specific control probe (M69 or 
M78). The probes were usually stained in two colours but single 
colour staining was also used for metaphase preparations. 
Metaphases (at least 15 per case) in which both chromosomes 22 
gave a signal with the control p be were scored for M51 signals 
in 22ql 1. Alternatively, interphase nuclei (at l ast 50 per case) 
with two signals for the control probe were scored for the number 
of M51 signals. In preparations ofnormal controls 95-100% of the 
metaphases and 90--95% of the interphase nuclei gave a double 
(dizygous) signal for M51, indicating the igh hybridization effi- 
ciency of both M51 and the control probe. 
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Southern analysis 
Genomic DNA, extracted from blood samples, cultured fibroblasts 
or established cell lines, was digested with restriction enzymes as 
recommended bythe manufacturer (Boehringer, Mannheim, Ger- 
many), separated by agarose gel electrophoresis and transferred to 
Hybond N § filters (Amersham, UK). DNA probes were labelled 
with [o~32p]dATP and [~32p]dCTP by using the random-primer 
method. 
A Zoo-blot, containing EcoRI-digested genomic DNA from 
human, Rhesus monkey, Sprague-Dawley rat, BALB/c mouse, 
dog, cow, rabbit, chicken and Saccharomyces cerevisiae yeast, 
was purchased from Clontech (Palo Alto, Calif.) and hybridized 
according to the manufacturer's in tructions (hybridization at 65 ~ 
C, wash in 2 x SSC at 60 ~ C). 
Fig. 1 Autoradiogram of Southern blot of EcoRI-digested DNA 
from human (DGS)-Chinese hamster hybrid cell lines hybridized se- 
quentially with probe NB84 (D22S183) and a probe from the im- 
munoglobulin 7.light chain complex (Ig~.) as a chromosome-22-spe- 
cific control. Cytogenetic analysis had shown one chromosome 22 in 
each hybrid line. Hybrid KH 11D carries the deleted chromosome 22; 
the other hybrids have retained the normal chromosome 22 
Results 
D22S 183 maps in the commonly deleted region 
To facilitate the screening of probes for their possible lo- 
cation in the commonly deleted region, we generated so- 
matic cell hybrids by fusing thymidine-kinase-deficient 
Chinese hamster cells with fibroblasts of two unrelated 
DGS patients both carrying a cytogenetic microdeletion i
22ql 1. Hybrid clones retaining one chromosome 22 were 
investigated for the presence of the locus D22S 134, by us- 
ing either the marker probe HP500 (Southern hybridiza- 
tion) or the corresponding cosmid sc4.1 (FISH). This lo- 
cus is hemizygous in more than 95% of cytogenetically 
normal DGS patients (Carey et al. 1992). In this way, hy- 
brid clones containing either the normal or the deleted 
chromosome 22 were identified. DNA isolated from these 
hybrids was investigated using Southern blot analysis 
with probes from various single-copy anonymous markers 
that have recently been assigned to the region 22pter-ql 1
(Van Biezen et al. 1993). One of the markers tested, NB84 
(locus D22S 183), appeared to map within the 22ql 1 dele- 
tion of both DGS patients whose fibroblasts were used to 
generate hybrid cell lines (Fig, 1). We therefore decided 
to investigate the map position of this locus and the ap- 
plicability of plasmid and cosmid probes in Southern and 
FISH analysis for the routine detection of deletions in 
CATCH22 in more detail. 
Hybridization of radiolabelled NB84 to a Zoo-blot 
containing EcoRl-digested DNA from various animal 
species produced a clear signal only with human and Rhe- 
sus monkey DNA (data not shown), leading to the con- 
clusion that D22S183 sequences are conserved in pri- 
mates. Weakly hybridizing fragments were also detected 
in other mammalian species (viz. cow, mouse, Chinese 
hamster). Hybridization of Northern blots containing 
poly-A + RNA from various adult human organs and from 
a fetus did not result in a signal, indicating that D22S183 
is probably not part of an expressed sequence. 
Isolation of cosmids M51 and M56 
Screening of the chromosome-22-specific gridded cosmid 
library L22NC031"N" with NB84 yielded three overlap- 
ping cosmids that were suitable for FISH (19B9, 33D9, 
83C5). All three mapped to band 22ql l  in metaphase 
chromosomes (Fig. 2a) and were hemizygous in the DGS 
patients mentioned above. In normal control interphase 
nuclei in G~ phase, each cosmid produced two hybridiza- 
tion signals. One of the cosmids, 33D9 (lab name M51), 
was used in further studies. Upon screening the chromo- 
some-22-specific l brary with NB84, a fourth weakly pos- 
itive cosmid clone, 38A6 (lab name M56), was identified 
that was not contiguous with the other cosmids. In situ hy- 
bridization of M56 on normal metaphase chromosomes 
gave a clear signal in 22ql 1, overlapping with M51. In in- 
terphase nuclei, however, M56 produced a signal close to, 
but separate from, the M51 signal, indicating that the two 
cosmids recognize different loci. 
Cosmid M51 maps within the SRO of CATCH22 
deletions and M56 is commonly deleted in DGS patients 
For a more detailed regional mapping of M51 and M56, 
we used the translocation cell lines ADU, GM05878 and 
GM00980. ADU is from a DGS patient with an appar- 
ently balanced translocation t(2;22)(q14.1;qll. l) (Au- 
gusseau et al. 1986). Cell line GM05878 contains a bal- 
anced translocation t(10;22)(q26.3;qll.2) and is from the 
unaffected father of a DGS child (Cannizzaro and 
Emanuel 1985). The child had monosomy 22pter-ql l  
(Kelley et al. 1982). FISH analysis howed both M51 and 
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9 Fig. 2a-h FISH analysis of metaphase chromosomes and G, inter- Position of TUPLEI, D22S75 (N25) 
phase nuclei. Direct photomicrographs, without digital enhaiace 2-'::~d>Z~iZ74 reiatNe to M51 and M56 
ment. Probes are coloured either in green (fluorescein) or in red 
(rhodamine/Texas Red) and DNA is counterstained in blue with 
DAPI. Fluorescence was registered using a triple-band filterset, a
Partial metaphase pread from lymphocyte culture of normal con- 
trol subject, hybridized with cosmid M51 (D22S183) labelled in 
red. Both chromosomes 22show a signal in the ql 1 region, b Par- 
tial metaphase pread from a lymphocyte culture of a DGS patient, 
hybridized with M51 (green) and the control probe M78 (red). 
M78 produces asignal on both chromosomes 22(at q13), but M51 
on only one, indicating hemizygosity, e d G 1 interphase nuclei 
from fibroblast cultures of a normal control subject (c) and a DGS 
patient (d), hybridized with M51 (green) and the chromosome-22- 
specific ontrol probe M78 (red). Both M78 and M51 produce two 
signals per nucleus in the control (e), whereas in the DGS nuclei 
(d), M78 produces two signals, but M51 only one. e Partial 
metaphase spread from the balanced translocation cell line 
GM05878, hybridized with M51 (red) and sc4.1 (green). In the 
normal chromosome 22 (arrowhead), the signals of M51 and sc4.1 
overlap, resulting in a white signal. The derivative 22 (small ar- 
row) shows a red signal for M51 and the derivative 10 (large ar- 
row) a green signal for sc4.1, indicating that the translocation 
breakpoint is between the two loci. f Partial metaphase spread 
from the unbalanced translocation cell line GM00980, hybridized 
with M51 (green) and M78 (red). The normal chromosome 22 (ar- 
row) shows proximal and distal signals for M51 and M78, respec- 
tively. The derivative 11 (arrowhead) shows a signal for M78 but 
not for M51, indicating that M51 is deleted and maps centromeric 
to the translocation breakpoint inthis cell line. g Partial metaphase 
spread from cell line GM00980, hybridized with N25 and the con- 
trol probe pill7, both in red (the two probes were supplied pre- 
mixed by the manufacturer, both labelled with digoxigenin, mak- 
ing two-colour hybridization impossible). The normal chromo- 
some 22 (arrow) shows proximal and distal signals for N25 and 
pill7, respectively. On the derivative 11 (arrowhead), only the 
distal signal is present, indicating that N25 is deleted and maps 
centromeric to the translocation breakpoint, h GI interphase nu- 
cleus from the fibroblast culture of a normal control subject. Triple 
hybridization with cosmids cH748 (red), M51 (green) and sc4.1 
(red). Both triplets how the order red-green-red. In one triplet, 
the green signal partially overlaps one of the red signals 
M56 to be located between the two translocation break- 
points in 22ql 1, i.e. telomeric to the ADU breakpoint and 
centromeric to the GM05878 breakpoint. An example is 
presented of a GM05878 metaphase cohybridized with 
cosmids M51 and sc4.1 (Fig. 2e). In agreement with Lind- 
say et al. (1993), sc4.1 was found to map telomeric to 
both the ADU and the GM05878 breakpoint and is there- 
fore telomeric to M51 and M56. 
Cell line GM00980 is from a VCFS patient and has an 
unbalanced translocation t(l l ;22)(q25;qll) with deletion 
22pter-qll (Fu et al. 1976). According to Lindsay et al. 
(1993), the breakpoints in GM00980 and GM05878 are 
close. By using FISH analysis on interphase nuclei and 
metaphase spreads of GM00980, we have found M51 to 
be hemizygous, i.e. absent from the derivative 11 translo- 
cation chromosome (Fig. 2f), whereas M56 is dizygous. 
This result places the GM00980 breakpoint between M51 
and M56 and shows that M56 is telomeric to M51. To- 
gether these data lead to the following order: cen-ADU 
breakpoint-M51 (D22S 183)-GM00980 breakpoint-M56- 
GM05878 breakpoint- el (see also Fig. 5). 
The recently described gene TUPLE1 (Halford et al. 
1993c) maps between the ADU and GM00980 break- 
points, i.e. in the same region as M51. A cosmid probe for 
TUPLE1 is cH748. Two-colour FISH of interphase nuclei 
showed the hybridization signals of cH748 and M51 to be 
frequently overlapping (47%, n = 212), indicating that the 
two loci are close. The centromeric-telomeric orientation 
of M51 and cH748 was determined by two-colour FISH, 
as described by Trask et al. (1991), by using sc4.1 as a 
distal reference point. In this experiment, cells synchro- 
nized in G 1 were hybridized simultaneously with M51 
coloured green and with cH748 and sc4.1 both coloured 
red. The order of the probes was then established by scor- 
ing the position of the green probe either between or out- 
side the two red probes. Only nuclei in which the three 
fluorescent spots were on a straight or obtusely angled 
line were scored. In the majority of nuclei (73%, n = 121), 
the order was red-green-red (Fig. 2h), suggesting that 
M51 is telomeric to cH748. 
Driscoll et al. (1992a, b, 1993) have described the lo- 
cus D22S75 (probe N25) as being deleted in the great ma- 
jority of DGS and VCFS patients. They have mapped this 
locus centromeric to the GM05878 breakpoint. Using a 
commercially available digoxigenin-labelled N25 probe, 
we have investigated the map position of the locus in 
more detail. FISH analysis of metaphases of the ADU and 
GM00980 cell lines showed N25 to map between the two 
translocation breakpoints (Fig. 2g), as do M51 and cH748 
(TUPLE1). The N25 probe is supplied pre-mixed with a 
digoxigenin-labelled control probe for a locus at 22q13.3. 
This locus is too far away to be used as a distal reference 
point in two-colour FISH analysis of G 1 interphase nuclei 
directed at determining the centromeric-telomeric o ienta- 
tion of N25 and M51. Therefore, M56 was used as a ref- 
erence marker. G~ interphase nuclei were hybridized si- 
multaneously with M51 and M56 coloured green and the 
N25 mix coloured red. Nuclei were selected in which the 
red signals (for N25 and the locus at 22q13.3) were suffi- 
ciently separate and in which two green signals (for M51 
and M56) were close to one red signal. The position of 
this red signal was then scored either between or outside 
the two green signals. In 64% of the cases (n = 158), the 
red signal was between the green signals, indicating that 
N25 is telomeric to M51. This conclusion was also sup- 
ported by the frequencies of overlapping hybridization 
signals in interphase nuclei hybridized with either N25 
and M51 (21% overlap, n = 178) or N25 and M56 (35% 
overlap, n = 118). Knowing that both N25 and M51 are 
centromeric to M56, these overlap frequencies indicate 
that N25 is telomeric to M51. 
Aubry et al. (1993) have shown that the zinc finger 
gene ZNF74 maps to 22ql I and is consistently deleted in 
DGS patients. Using a cosmid probe (cos39), we have in- 
vestigated, by FISH, the position of this gene relative to 
the translocation breakpoints of ADU, GM00980 and 
GM05878. In all three cell lines, ZNF74 mapped telom- 
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eric to the translocation breakpoint in 22ql 1. The position 
of ZNF74 was then established relative to the sc 11.1B lo- 
cus (D22S 139). Cosmid sc 11.1 (Halford et al. 1993a) rec- 
ognizes two loci, sc l l . lA  and scl l . lB,  that are approxi- 
mately 2 Mb apart and that are commonly deleted to- 
gether in DGS patients (Desmaze t al. 1993b; Lindsay et 
al. 1993). Locus sc l l . lA  is centromeric to the ADU 
breakpoint and sc l l . lB  is telomeric to the GM05878 
breakpoint. The hybridization signals for the two loci are 
not distinguishable on metaphase chromosomes but are 
separate in interphase nuclei. To establish whether ZNF74 
is between or outside the sc 11. l loci, Gl interphase nuclei 
were hybridized simultaneously with cos39 coloured 
green and sc 11.1 coloured red and the order of the probes 
was scored. In 65% of the cases (n = 203), the order was 
red-red-green, suggesting that ZNF74 is telomeric to 
sc 11. lB. The distance between these loci can be no more 
than a few hundred kilobase pairs, since there was a fre- 
quent overlap between the green signal and one of the red 
signals. 
CATCH22 patient analysis 
Fig. 4 Quantitative Southern analysis of PstI-digested DNA from 
two patients (lanes 3, 4) and a control subject (lanes 1.2; in lane 
2, a double amount of DNA was loaded). The blot was hybridized 
simultaneously with probe NB84 (locus D22S183) and aprobe for 
the ~-globin locus as a control. Comparison of the signal intensi- 
ties produced by the test probe and the control probe shows that 
one patient (lane 3), who was diagnosed as having VCFS, is hem- 
izygous for D22S 183. The other patient (lane 4) is heterozygous 
for the PstI polymorphism in D22S 183 and therefore has no dele- 
tion at this locus. This patient has congenital heart disease and mi- 
nor facial dysmorphisms 
Hemizygosity assays were performed using blood sam- 
ples and/or skin fibroblast cultures of 12 DGS and seven 
VCFS patients and, in some cases, their parents. Cytoge- 
netic analysis revealed a microdeletion in three DGS 
cases. All other subjects were karyotypically normal. In 
addition to the patient material collected in Rotterdam, we 
also analysed the previously described cell line GM03479, 
which has been derived from a DGS patient but in which, 
so far, no hemizygosity has been detected (Scambler et al. 
1991). 
Hemizygosity for the locus D22S183 was studied in 
three different ways: restriction fragment length polymor- 
phism (RFLP) analysis, quantitative Southern analysis 
and FISH. In Southern analysis of PstI-digested genomic 
DNA, a polymorphism recognized by NB84 is in some 
cases informative for the detection of deletions (Fig. 3). 
Two allelic bands of 6.0 and 4.7 kb can be detected (the 
sizes of the PstI fragments have previously been incor- 
Fig. 3 Autoradiogram of Southern blot of Pstl-digested DNA from 
a proband and her parents, hybridized with probe NB84 (locus 
D22S183), which reveals a polymorphism in this family. The 
mother and father are homozygous for the 4.6-kb and 4.0-kb allele, 
respectively. The proband failed to inherit a maternal allele 
rectly assessed at 4.6 and 4.0 kb; Lekanne Deprez et al. 
1991). The estimated frequencies among Caucasians are 
0.81 and 0.19 for the 6.0-kb and 4.7-kb bands respectively 
(Lekanne Deprez et al. 1991). In a series of 38 consecu- 
tive patients (DGS, VCFS and non-syndromic congenital 
heart disease), the PstI polymorphism was informative in 
12 cases. If no informative polymorphism was found, 
hemizygosity for D22S183 was studied by quantitative 
Southern analysis of PstI-digested genomic DNAs. Filters 
were hybridized simultaneously with radiolabelled NB84 
and a probe from the [3-globin gene as a control. The lat- 
ter probe recognizes a fragment of 4.4 kb, which is in the 
same range as the NB84 fragments. From the autoradi- 
ogram (Fig. 4), the dosage of the D22S183 locus was es- 
tablished by comparing the intensities of the hybridization 
signals of the two probes. 
FISH analysis with the cosmid probe M51 was found 
to be a rapid reliable hemizygosity assay. Metaphase 
spreads or preparations of cultures that had been enriched 
for G 1 interphase cells were simultaneously hybridized 
with M51 and a chromosome-22-specific control cosmid 
corresponding tothe PDGFB locus at 22q 13.1 (Fig. 2b-d). 
In case of a deletion, 100% of the metaphases and 
97-100% of the interphase nuclei that revealed a double 
(dizygous) signal with the control probe were scored as 
hemizygous for M51. 
Eleven out of 12 DGS patients and 3 out of 7 VCFS 
patients were hemizygous for the D22S183 locus. In all 
cases, Southern and FISH analyses led to identical con- 
clusions. In view of speed and reliability of diagnosis, 
FISH using cosmid M51 is the method of choice for the 
detection of 22qll deletions. Two DGS patients had in- 
herited the deletion from a parent. The hemizygous 
mother of one patient had been operated for tet alogy of 
Fa lot at the age of 6 years. The other patient inherited the 
Table 1 Clinical features of four 
VCFS patients and one DGS pa- 
tient without detectable 22ql 1 
deletion (+ presence of clinical 
trait, - absence of clinical trait, 
nd no data available, (a) mother 
and daughter, (b) sister has 
VCFS dysmorphic features but 
no cardiac defect, (c) mother has 
prominent nose, cardiac mur- 
mur, (d) sib has mental retarda- 
tion, dysmorphic face, deafness) 
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VCF-Ro2 VCF-Ro3 VCF-Ro5 VCF-Ro6 DG-Ro9 
Cardiac defects + + + + + 
Typical facies + + + + + 
Palatal abnormalities nd nd + + + 
Learning disabilities nd nd + nd nd 
Clinodactyly nd + + + - 
Decreased lymphoid tissue nd nd nd nd + 
Other (a) (a) (b) (c) (d) 
deletion from her father, who suffers from psychiatric ill- 
ness but has no physical abnormalities. To obtain an indi- 
cation of the size of the deletions, FISH analysis was also 
performed with the cosmid probes sc4.1 and scl l .1. All 
cases hemizygous for D22S183 (patients and parents) 
were also hemizygous for sc4.1 and for both scl 1.1 loci (A 
and B), suggesting that the deletions pan at least 2 Mb. 
One DGS case, four VCFS cases and the cell line 
GM03479 were dizygous for D22S183 (clinical features 
of these patients are given in Table 1). No hemizygosity 
for sc4.1, scl 1.1 or the TUPLE1 cosmid cH748 was de- 
tected in the DGS patient and one VCFS patient. 
Discuss ion  
An SRO of 22ql 1 deletions associated with DGS and VCFS 
has been delineated in several recent publications (Driscroll 
et al. 1992a; Desmaze t al. 1993a; Lindsay et al. 1993; Hal- 
ford et al. 1993c). It has not been possible to narrow the SRO 
to an interval smaller than approximately 500 kb, suggesting 
that CATCH22 might be a contiguous gene syndrome. 
By using the cosmid probe M51, we have determined 
the map position of  the anonymous marker locus 
D22S183 relative to a number of  translocation break- 
points and other known loci. D22S183 maps within the 
SRO. A second locus, recognized by cosmid M56, which 
contains sequences with weak homology to D22S183, is 
located more distally, just outside the SRO. A positional 
map is presented in Fig. 5. Recently, Halford et al. 
(1993c) have described the gene TUPLE1, which encodes 
a putative transcriptional regulator and which is located 
close to (on the distal side of) the balanced t(2;22) translo- 
cation breakpoint in the DGS patient ADU. Although 
there is no indication yet that the gene is disrupted or that 
its expression is disturbed by the ADU translocation, it is 
reasonable to suppose that haplo-insufficiency for TU- 
PLE1 contributes to the malformations in DGS and 
VCFS. Another locus of  interest, D22S75 (probe N25), is 
in the SRO of the DGS and VCFS deletions described by 
Driscoll et al (1992a). D22S75 is adjacent o a Not I  site 
that is located in an HTF island (McDermid et al. 1989) 
and may therefore be at the 5' end of a gene. In the pre- 
sent investigation, it is shown that D22S75 is between the 
ADU and GM00980 breakpoints and therefore within the 
SRO described by Halford et al. (1993c). The order of  
markers in the SRO was determined to be TUPLE1 - 
D22S183 - D22S75 (Fig. 5), the TUPLE1-D22S183 in- 
terval being shorter than the D22S183-D22S75 interval. 
According to Halford et al. (1993c), the interval between 
TUPLE1 and the GM00980 breakpoint should be less 
than 275 kb. We therefore stimate D22S75 to be close to 
this breakpoint and D22S 183 to be less than 200 kb from 
TUPLE1. In the absence of evidence that deletion or mu- 
tation of TUPLE1 is sufficient to cause CATCH22, the 
identification of other genes in the SRO remains an im- 
translocetion t(2;22) 




probe scl 1.1 
TUPLE1 D22S183 DLT2S75 
cH748 M51 N25 
NB84 
, ~, SRO of VCFS dele~ons 
i 
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,, ~ SRO of DGS delet ions 
i 
, ,, commonly deleted region 
Fig. 5 Diagram of the DiGeorge chromosomal region at 22ql 1 
showing the relative order of loci and translocation breakpoints 
studied. Vertical lines Position of translocation breakpoints, rec- 




D22S134 sc11.1B 2NF74 
8c4.1 sc11.1 cos39 
HPSO0 
,7 
tangles loci (genes). The probes (cosmids and plasmids) used in 
the present study are indicated for each locus. Chromosomal dis- 
tances have not been drawn to scale 
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portant issue. In this respect, D22S75 and D22S183 may 
be relevant loci. 
The region that is commonly deleted in the majority of 
patients is considerably larger than the SRO. Most 
CATCH22 deletions extend over a distance of more than 
2 Mb, usually including the sc I 1.1B locus (Desmaze t al. 
1993a, b; Halford et al. 1993c), as was also shown in our 
patient series. However, there is some indication that a 
less distal extension of a deletion is more l ikely to be as- 
sociated with VCFS than with DGS. According to Hal- 
ford et al. (1993c), a deletion not including the sc l l . lB  
locus has been found in 7 out of 91 DGS and 6 out of 16 
VCFS cases (in their Table 1, the patient with deletion 
C1/79-sc l l . lA  is the child of GM05878 and the patient 
with deletion scF5-sc l l . lA  is the GM0980 case; in the 
Table, these should be interchanged as DGS and VCFS, 
respectively; personal communicat ion Dr. RJ. Scambler). 
In six of the seven DGS cases, the deletion includes the 
D22S134 (sc4.1) locus, whereas in the six VCFS cases, 
the deletion does not extend distally to this locus. The 
only DGS patient who probably had a deletion not ex- 
tending so far distally is the child of GM05878. For 
VCFS, the most centromeric distal deletion boundary is 
found in GM00980. This means that haplo-insuff iciency 
for a gene or genes in the region between the GM00980 
and GM05878 breakpoints, and perhaps also in the adja- 
cent distal region, might play a specific role in the patho- 
genesis of DGS. The cosmids M56 (present investiga- 
tion), C1/79 (Halford 1993c), and D0832 (Lindsay et al. 
1993) could help in finding such genes. Furthermore, 
genes located more distal ly but within the commonly 
deleted region, such as COMT (Dunham et al. 1992; Des- 
maze et al. 1993a), T10 (Halford et al. 1993b) and the 
zinc f inger gene ZNF74 (Aubry et al. 1993), might con- 
tribute to the clinical phenotype in CATCH22 patients. 
Although ZNF74 was found to be deleted in 23 out of 24 
DGS patients (Aubry et al. 1993), our F ISH analysis now 
shows that the gene maps close to, and possibly distal to, 
scl 1.1B, i.e. far outside the SRO. 
Family members with apparently identical 22ql 1 dele- 
tions can be either mildly or severely affected. In two of 
the DGS cases studied here, the deletion was inherited 
from a parent. In both cases, the parent does not have 
the DGS or VCFS phenotype. The mother of one patient 
has been operated on for tetralogy of Fallot. The father of 
the other patient suffers from psychiatric il lness but has 
no physical complaints. Inheritance of  a 22ql 1 deletion 
with increased severity of the clinical phenotype in the 
second generation has been reported (Wilson et al. 1991, 
1992b; Desmaze et al. 1993a; Driscroll  et al. 1993). Our 
f indings once more indicate that, if an individual with iso- 
lated conotruncal heart defect is found to have a 22q l l  
deletion, there is a risk of more complicated malforma- 
tions in the offspring. 
A small number of DGS and a larger number of VCFS 
patients have been described in whom no hemizygosity was 
found for any of the loci investigated (Halford et al. 1993c). 
The prevalence of such cases may depend on the strictness 
of the diagnostic riteria (Driscroll et al. 1993). Moreover, 
in our series, one DGS and four VCFS cases, and the cell 
line GM03479 revealed no hemizygosity. Patient DG-Ro9 
(Table 1) has the major features of DGS but he has a dys- 
morphic mentally retarded brother with no DGS features, 
indicating that the malformations might have another basis 
in this family. The VCFS patients included in Table 1 all 
have the major features of the syndrome. In addition, a ge- 
netic aetiology is suggested by the fact that, in all four 
cases, family members have VCFS dysmorphic features. 
An explanation could be that either there is a second VCFS 
locus or the mutation in 22ql I cannot be detected with our 
present methods. An indication for a second DGS locus 
comes from patients with a deletion in 10pl3 (Greenberg et 
al. 1988; Monaco et al. 1991). Alternatively, the disease 
does not have a genetic basis in the non-deleted cases. 
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